Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology

Published:2018-01-02 Issue:1 Volume:36 Page:37-58
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Zarredar Habib¹²,Ansarin Khalil¹,Baradaran Behzad³,Ahdi Khosroshahi Shiva⁴,Farajnia Safar¹⁴

Affiliation:

1. Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Science, Tabriz, Iran

2. Students Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

3. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

4. Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Funder

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Science. Tabriz, Iran

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2017.1416393

Reference174 articles.

1. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

2. Cancer statistics, 2015

3. Combined cell-gene therapy for lung cancer: rationale, challenges and prospects

4. Novel therapeutic targets on the horizon for lung cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Codelivery of curcumin and siRNA as anticancer therapeutics;Curcumin-Based Nanomedicines as Cancer Therapeutics;2024

2. Evaluation of Potential miR-302, miR-132, miR-205, and miR-126 as Biomarkers for Laryngeal Squamous Cell Carcinoma;International Journal of Cancer Management;2023-12-30

3. MicroRNA-Based Biomarkers in Lung Cancer: Recent Advances and Potential Applications;Current Molecular Medicine;2023-08

4. The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses;International Journal of Molecular Sciences;2023-03-24

5. The potential of B7-H6 as a therapeutic target in cancer immunotherapy;Life Sciences;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3